semaglutide discontinuation study denmark 2025 september Most quit breakthrough weight-loss drug within a year Impact of CVS GLP-1 formulary

BrandShield CEO Yoav Keren showed CNBC various sites that the company flagged and that ultimately got shut down, including a Facebook account and a TikTok account that impersonated GLP-1 makers and sold versions of the drug

Five times the dose from the same syringe marking

The correlation between early tolerance and continued tolerance is strong

The team developed a high-specificity mass spectrometry assay that detects only the bioactive form of GLP-1 -- the version that actually stimulates insulin -- not the inactive fragments that often muddy results

The semaglutide is the same active ingredient in both forms. Semaglutide comes with common digestive side effects like: Other side effects may include fatigue, headaches and low blood sugar (hypoglycemia) if semaglutide is combined with other drugs that lower blood sugar, like insulin

Despite any side effects, Semaglutide presents a promising avenue for medically-supervised weight loss, especially for those who have not found success with traditional methods